Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 91 (RPL21P91) is a processed pseudogene related to the gene encoding ribosomal protein L21. Pseudogenes like RPL21P91 are non-functional copies of protein-coding genes, generated through gene duplication or retrotransposition events, and generally do not produce functional protein products. They are common for genes encoding ribosomal proteins, with multiple pseudogenes found for RPL21 distributed throughout the genome. RPL21P91 itself does not code for an active ribosomal protein or have an established biological role. It is not considered a therapeutic target, is not associated with known disease processes, and does not interact with any approved drugs or experimental compounds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 91 (RPL21P91).